CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial Can the Vanishing Stent Reappear? Fix the Technique, or Fix the Device? Percutaneous Coronary Intervention Readmissions Where Are the Solutions? Basic Biology of Oxidative Stress and the Cardiovascular System: Part 1 of a 3-Part Series 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC)he management of patients with) Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry Impact of Coronary Lesion Complexity in Percutaneous Coronary Intervention: One-Year Outcomes From the Large, Multicentre e-Ultimaster Registry Poor R-wave progression as a predictor of sudden cardiac death in general population and subjects with coronary artery disease

Original Research

JOURNAL:Eur Heart J. Article Link

Systemic microvascular dysfunction in microvascular and vasospastic angina

Ford TJ, Rocchiccioli P, Good R et al. Keywords: coronary microvascular dysfunction; vasospasm; ischaemia with no obstructive coronary artery disease; peripheral small artery; microvascular angina; vasospastic angina; endothelin-1; endothelial dysfunction; vasoconstriction

FULL TEXT PDF